• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Mentice

13.50 SEK+1.50 %13/7 15:06
Less than 1K followers

MNTC

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.50 %
+7.14 %
+1.50 %
-2.17 %
+1.12 %
-2.37 %
-67.07 %
-84.25 %
-79.78 %

Mentice operates in the medical technology sector. The company develops medical instruments for endovascular simulation and for training sessions in surgery. The programs are developed for use in educational purposes among hospitals and institutes. The largest operations are found in North America and Europe. In addition to the main business, opportunities for leasing, support, and technical service are offered. The headquarters are located in Gothenburg.

Read more
Market cap
379.7M SEK
Turnover
1.12K SEK
Revenue
279.09M
EBIT %
-9.88 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
23/7
2026

Interim report Q2'26

10/11
2026

Interim report Q3'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release2026-07-10 13:05

Mentice to Present Q2 2026 Interim Report via Webcast

Mentice
Press release2026-07-09 17:45

DNB Carnegie Access: Mentice: Don’t stop delivering – Q2 preview

Mentice
Regulatory press release2026-07-01 20:00

Correction: Missing MAR label in earlier Press Release - Mentice secures $2.4M in several orders from one Top 20 Global MedTech Company within Interventional Cardiology

Mentice

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-07-01 20:00

Rättelse: Avsaknad av MAR-märkning i tidigare pressmeddelande - Mentice erhåller flera ordrar värda 2,4 MUSD från ett globalt topp 20-bolag inom medicinteknik för interventionell kardiologi

Mentice
Press release2026-06-30 08:05

DNB Carnegie Access: Mentice: Top 20 medtech order further reinforces momentum in MDI

Mentice
Regulatory press release2026-06-29 18:00

Mentice secures $2.4M in several orders from one Top 20 Global MedTech Company in Interventional Cardiology, focused on Structural Heart Disease

Mentice
Regulatory press release2026-06-29 18:00

Mentice erhåller flera ordrar värda 2,4 MUSD från ett globalt topp 20-bolag inom medicinteknik för interventionell kardiologi med fokus på strukturell hjärtsjukdom

Mentice
Press release2026-06-01 20:00

Mentice och Siemens Healthineers tillkännager marknadsföringsavtal för att stärka planeringen av neurovaskulär behandling

Mentice
Press release2026-06-01 20:00

Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning

Mentice
Regulatory press release2026-05-26 22:00

Communique from annual general meeting in Mentice AB

Mentice
Regulatory press release2026-05-26 22:00

Kommuniké från årsstämma i Mentice AB

Mentice
Press release2026-05-08 07:00

DNB Carnegie Access: Mentice: Three consecutive quarters of improvement – Q1 review

Mentice
Press release2026-05-07 08:30

DNB Carnegie Access: Mentice: Reinforcing the recovery narrative – Q1 initial

Mentice
Regulatory press release2026-05-07 07:00

DELÅRSRAPPORT JAN–MAR 2026

Mentice
Regulatory press release2026-05-07 07:00

INTERIM REPORT JAN–MAR 2026

Mentice
Regulatory press release2026-04-24 21:15

Kallelse till årsstämma i Mentice AB

Mentice
Regulatory press release2026-04-24 21:15

Annual shareholders’ meeting in Mentice AB

Mentice
Press release2026-04-23 10:00

Mentice AB Publishes Annual and Sustainability Report for 2025

Mentice
Press release2026-04-23 10:00

Mentice AB publicerar års- och hållbarhetsredovisning för 2025

Mentice
Press release2026-04-21 09:00

Mentice to Present Q1 2026 Interim Report via Webcast

Mentice